Gastric adenocarcinoma of the intestinal type is believed to develop through a series of histopathologic stages, originally described by Correa,
1 Correa P. A human model of gastric carcinogenesis.
Cancer Res. 1988; 48 : 3554-3560 PubMed Google Scholar
that include chronic gastritis, gastric atrophy, intestinal metaplasia, dysplasia, and finally cancer. Intestinal metaplasia has been the focus of great fascination by many pathologists, because it was unexpected to find intestinal type mucosa containing goblet cells in the body or antrum of the stomach. Numerous studies have implicated intestinal metaplasia as a useful biomarker for gastric cancer risk, and even possibly a precursor to gastric malignancy. However, this evidence has been largely correlative. In patients with gastric cancer, intestinal metaplasia is frequently found in the stomach, even with early gastric cancer. Intestinal metaplasia is much more prevalent in high-risk areas for gastric cancer compared with low-risk areas. Finally, in several studies where serial endoscopies and biopsies were performed, patients with intestinal metaplasia, particularly type III, frequently developed gastric cancer.
2 Rokkas T. Filipe M.I. Sladen G.E. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up.
Gut. 1991; 32 : 1110-1113 Crossref PubMed Scopus (196) Google Scholar
Intestinal metaplasia has been used as the key biomarker in studies of
Helicobacter pylori eradication or gastric cancer prevention, defining the preneoplastic lesion often considered the “point of no return.”
3 Zivny J. Wang T.C. Yantiss R. et al. 2003 Role of therapy or monitoring in preventing progression to gastric cancer.
J Clin Gastroenterol. 2003; 36 : S50-S60 Crossref PubMed Scopus (20) Google Scholar
Indeed, because the gastric cancers that developed in this setting also showed intestinal differentiation, it seemed logical to conclude that the cancers arose directly from these intestinal metaplastic cells. Nevertheless, in contrast with other neoplasms, little genetic mutational evidence exists to implicate intestinal metaplastic lineages as true direct precursors of gastric neoplasia.